A Rational ResponseWould appreciate your thoughts on the latest earnings from QIPT and whether to hold, add, or sell with an explanation. EPS of a loss of 3c missed estimates of (nil); revenue of $63.95M missed estimates of $65.51M. EBITDA of $14.89M missed estimates of $15.07M. Results were hit by the discontinuation of Medicare 75/25 relief, which was subsidizing patient costs in several areas. QIPT also experienced the withdrawal of Medicare Advantage members due to an agreement with other providers and it was also indirectly impacted by a main healthcare admin company's cyber-security incident which impaired its ability to process and bill claims. That said, overall revenue rose 10% and QIPT says it is still experiencing 'strong trends for respiratory equipment'. The stock took a big hit on the news, and is now down 28% YTD. Cash flow and the balance sheet are still strong. We do not like the momentum here, but its outlook is still OK, and to be fair to the company, most of its issues in the quarter were beyond its control. We would see it as a HOLD after today's decline. (5iResearch)